Role of the Social Worker in Advance Care Planning
Note: Institutional group rates are available upon request
Select type to purchase:
Funding Disclosure: No commercial funding has been accepted for the activity.
Adam Schoenfarber, LCSW
Social Work Manager
MJHS Hospice and Palliative Care
Purpose: The purpose of this webinar is to assist social workers to acquire the knowledge and skills to identify and address difficult decisions and manage conversations in end-of-life care.
- Identify barriers and implement strategies to addressing difficult topics in end-of-life care
- Develop a working knowledge of advance directives and language to discuss these with families and patients
- Utilize the surrogacy hierarchy as set out in the Family Healthcare Decisions Act
Why Do I Need to Know This?
Patient-centered care is based upon decision-making and advance care planning commensurate with the values and wishes of the patient and family. Yet social workers are not well-trained in advance care planning and may therefore avoid difficult conversations at the end of life. A working knowledge of advance directives and exposure to best practices will enable the social worker to participate more fully in end-of-life communication and decision-making.
Target Audience: Social workers and healthcare coaches
Criteria for Successful Completion:
- Attendance at entire session
- Submission of completed evaluation form
- Successful completion of a posttest (80% passing grade)
Continuing Education Credits: 1.0
Release Date: August 29, 2018
Expiration Date: January 31, 2019
Continuing Education Accreditation:
Social Workers: MJHS Institute for Innovation in Palliative Care SW CPE is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #0242.
Individual: $25 (includes CE certificate)
Adam Schoenfarber, LCSW, has no financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in these materials. Any discussion of investigational or unlabeled uses of a product will be identified.
Russell K. Portenoy, MD, Faculty and Planner, has indicated a relationship with Tabula Rasa for research support.
No other Planning Committee Member has any disclosures.
Planning Committee Members
Lara Dhingra, PhD
Colleen Fleming-Damon, PhD, ANP-BC, ACHPN, FT
Myra Glajchen, DSW
Helena Knotkova, PhD
Russell K. Portenoy, MD
Karen Richards, PhD, EdS
Wini Schein, BA